B. Hoen, F. Bonnet, C. Delaugerre, P. Delobel, C. Goujard et al., French 2013 guidelines for antiretroviral therapy of HIV-1 infection in adults, Journal of the International AIDS Society, vol.17, issue.1, 2014.
DOI : 10.7448/IAS.17.1.19034

I. Williams, D. Churchill, J. Anderson, M. Boffito, M. Bower et al., British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012 (Updated November 2013. All changed text is cast in yellow highlight.), HIV Med, vol.15, pp.1-85, 2014.

J. Ananworanich, A. Schuetz, C. Vandergeeten, I. Sereti, D. Souza et al., Impact of Multi-Targeted Antiretroviral Treatment on Gut T Cell Depletion and HIV Reservoir Seeding during Acute HIV Infection, PLoS ONE, vol.355, issue.3, p.33948, 2012.
DOI : 10.1371/journal.pone.0033948.t002

B. Taiwo, R. Matining, L. Zheng, M. Lederman, C. Rinaldo et al., Associations of T cell activation and inflammatory biomarkers with virological response to darunavir/ritonavir plus raltegravir therapy, Journal of Antimicrobial Chemotherapy, vol.68, issue.8, pp.1857-61, 2013.
DOI : 10.1093/jac/dkt120

L. Hocqueloux, V. Avettand-fenoel, S. Jacquot, T. Prazuck, E. Legac et al., Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts, Journal of Antimicrobial Chemotherapy, vol.68, issue.5
DOI : 10.1093/jac/dks533

M. Wawer, R. Gray, N. Sewankambo, D. Serwadda, X. Li et al., Rates of HIV???1 Transmission per Coital Act, by Stage of HIV???1 Infection, in Rakai, Uganda, The Journal of Infectious Diseases, vol.191, issue.9, pp.1403-1412, 2005.
DOI : 10.1086/429411

S. Fidler, K. Porter, F. Ewings, J. Frater, G. Ramjee et al., Short-course antiretroviral therapy in primary HIV infection, N Engl J Med, vol.368, pp.207-224, 2013.

C. Hogan, V. Degruttola, X. Sun, S. Fiscus, D. Rio et al., The Setpoint Study (ACTG A5217): Effect of Immediate Versus Deferred Antiretroviral Therapy on Virologic Set Point in Recently HIV-1-Infected Individuals, Journal of Infectious Diseases, vol.205, issue.1, pp.87-96, 2012.
DOI : 10.1093/infdis/jir699

R. Seng, C. Goujard, L. Desquilbet, M. Sinet, C. Rouzioux et al., Rapid CD4+ Cell Decrease After Transient cART Initiated During Primary HIV Infection (ANRS PRIMO and SEROCO Cohorts), JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.49, issue.3, pp.251-259, 2008.
DOI : 10.1097/QAI.0b013e318189a739

M. Grijsen, F. Wit, S. Jurriaans, F. Kroon, E. Schippers et al., Temporary Treatment during Primary HIV Infection Does Not Affect Virologic Response to Subsequent Long-Term Treatment, PLoS ONE, vol.67, issue.(3), p.89639, 2014.
DOI : 10.1371/journal.pone.0089639.t001

C. Goujard, I. Girault, C. Rouzioux, C. Lecuroux, C. Deveau et al., HIV-1 control after transient antiretroviral treatment initiated in primary infection: role of patient characteristics and effect of therapy, Antiviral Therapy, vol.17, issue.6, pp.1001-1010, 2012.
DOI : 10.3851/IMP2273

S. Lodi, L. Meyer, A. Kelleher, M. Rosinska, J. Ghosn et al., Immunovirologic Control 24 Months After Interruption of Antiretroviral Therapy Initiated Close to HIV Seroconversion, Archives of Internal Medicine, vol.172, issue.16, pp.1252-1257, 2012.
DOI : 10.1001/archinternmed.2012.2719

A. Saez-cirion, C. Bacchus, L. Hocqueloux, V. Avettand-fenoel, I. Girault et al., Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study, PLoS Pathogens, vol.22, issue.16, p.1003211, 2013.
DOI : 10.1371/journal.ppat.1003211.s007

URL : https://hal.archives-ouvertes.fr/pasteur-01420534

E. Krastinova, R. Seng, P. Yeni, J. Viard, D. Vittecoq et al., Is Clinical Practice Concordant with the Changes in Guidelines for Antiretroviral Therapy Initiation during Primary and Chronic HIV-1 Infection? The ANRS PRIMO and COPANA Cohorts, PLoS ONE, vol.365, issue.8, p.71473, 2013.
DOI : 10.1371/journal.pone.0071473.t003

URL : https://hal.archives-ouvertes.fr/hal-00874822

M. Chaix, R. Seng, P. Frange, L. Tran, V. Avettand-fenoel et al., Increasing HIV-1 Non-B Subtype Primary Infections in Patients in France and Effect of HIV Subtypes on Virological and Immunological Responses to Combined Antiretroviral Therapy, Clinical Infectious Diseases, vol.56, issue.6, pp.880-887, 2013.
DOI : 10.1093/cid/cis999

Y. Levy, R. Thiebaut, M. Gougeon, J. Molina, L. Weiss et al., Effect of intermittent interleukin-2 therapy on CD4+ T-cell counts following antiretroviral cessation in patients with HIV, AIDS, vol.26, issue.6, pp.711-731, 2012.
DOI : 10.1097/QAD.0b013e3283519214

C. Goujard, F. Marcellin, H. Hendel-chavez, M. Burgard, V. Meiffredy et al., Interruption of Antiretroviral Therapy Initiated during Primary HIV-1 Infection: Impact of a Therapeutic Vaccination Strategy Combined with Interleukin (IL)-2 Compared with IL-2 Alone in the ANRS 095 Randomized Study, AIDS Research and Human Retroviruses, vol.23, issue.9, pp.1105-1118, 2007.
DOI : 10.1089/aid.2007.0047

C. Goujard, D. Emilie, C. Roussillon, V. Godot, C. Rouzioux et al., Continuous versus intermittent treatment strategies during primary HIV-1 infection, AIDS, vol.26, issue.15, pp.1895-905, 2012.
DOI : 10.1097/QAD.0b013e32835844d9

URL : https://hal.archives-ouvertes.fr/hal-00875175

C. Claassen, M. Diener-west, S. Mehta, D. Thomas, and G. Kirk, Discordance Between CD4+ T-Lymphocyte Counts and Percentages in HIV-Infected Persons With Liver Fibrosis, Clinical Infectious Diseases, vol.54, issue.12, pp.1806-1819, 2012.
DOI : 10.1093/cid/cis294

M. Battegay, R. Nuesch, B. Hirschel, and G. Kaufmann, Immunological recovery and antiretroviral therapy in HIV-1 infection, The Lancet Infectious Diseases, vol.6, issue.5, pp.280-287, 2006.
DOI : 10.1016/S1473-3099(06)70463-7

G. Touloumi, N. Pantazis, H. Stirnadel, A. Walker, F. Boufassa et al., Rates and Determinants of Virologic and Immunological Response to HAART Resumption After Treatment Interruption in HIV-1 Clinical Practice, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.49, issue.5, pp.492-500, 2008.
DOI : 10.1097/QAI.0b013e318186ead2

C. Mussini, A. Cossarizza, C. Sabin, A. Babiker, D. Luca et al., Decline of CD4+ T-cell count before start of therapy and immunological response to treatment in antiretroviral-naive individuals, AIDS, vol.25, issue.8, pp.1041-1050, 2011.
DOI : 10.1097/QAD.0b013e3283463ec5

A. Mocroft, A. Phillips, J. Gatell, B. Ledergerber, M. Fisher et al., Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study, The Lancet, vol.370, issue.9585, pp.407-420, 2007.
DOI : 10.1016/S0140-6736(07)60948-9

B. Ledergerber, J. Lundgren, A. Walker, C. Sabin, A. Justice et al., Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes, The Lancet, vol.364, issue.9428, pp.51-62, 2004.
DOI : 10.1016/S0140-6736(04)16589-6

A. Lifson, E. Krantz, L. Eberly, M. Dolan, V. Marconi et al., Long-term CD4+ lymphocyte response following HAART initiation in a U.S. Military prospective cohort, AIDS Research and Therapy, vol.8, issue.1, 2011.
DOI : 10.1186/1742-6405-8-2

N. Pakker, D. Notermans, D. Boer, R. Roos, M. et al., Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferation, Nature Medicine, vol.41, issue.2, pp.208-222, 1998.
DOI : 10.1016/0022-1759(89)90260-3

W. El-sadr, J. Lundgren, J. Neaton, F. Gordin, D. Abrams et al., CD4+ count-guided interruption of antiretroviral treatment, N Engl J Med, vol.355, pp.2283-96, 2006.

C. Mussini, G. Touloumi, G. Bakoyannis, C. Sabin, A. Castagna et al., Magnitude and Determinants of CD4 Recovery After HAART Resumption After 1 Cycle of Treatment Interruption, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.52, issue.5, pp.588-94, 2009.
DOI : 10.1097/QAI.0b013e3181b9e94d

L. Kuller, R. Tracy, W. Belloso, D. Wit, S. Drummond et al., Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection, PLoS Medicine, vol.180, issue.10, p.203, 2008.
DOI : 10.1371/journal.pmed.0050203.sd002

A. Cozzi-lepri, M. French, J. Baxter, P. Okhuysen, M. Plana et al., Resumption of HIV replication is associated with monocyte/macrophage derived cytokine and chemokine changes: results from a large international clinical trial, AIDS, vol.25, issue.9, pp.1207-1224, 2011.
DOI : 10.1097/QAD.0b013e3283471f10

S. Deeks, C. Kitchen, L. Liu, H. Guo, R. Gascon et al., Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load, Blood, vol.104, issue.4, pp.942-949, 2004.
DOI : 10.1182/blood-2003-09-3333

L. Roberts, J. Passmore, C. Williamson, F. Little, L. Bebell et al., Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression, AIDS, vol.24, issue.6, pp.819-850, 2010.
DOI : 10.1097/QAD.0b013e3283367836

P. Sax, C. Tierney, A. Collier, M. Fischl, K. Mollan et al., Abacavir???Lamivudine versus Tenofovir???Emtricitabine for Initial HIV-1 Therapy, New England Journal of Medicine, vol.361, issue.23, pp.2230-2270, 2009.
DOI : 10.1056/NEJMoa0906768

T. Le, E. Wright, D. Smith, W. He, G. Catano et al., Enhanced CD4+ T-Cell Recovery with Earlier HIV-1 Antiretroviral Therapy, New England Journal of Medicine, vol.368, issue.3, pp.218-248, 2013.
DOI : 10.1056/NEJMoa1110187

D. Persaud, H. Gay, C. Ziemniak, Y. Chen, P. Jr et al., Absence of Detectable HIV-1 Viremia after Treatment Cessation in an Infant, New England Journal of Medicine, vol.369, issue.19, pp.1828-1863, 2013.
DOI : 10.1056/NEJMoa1302976